Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study.
Journal: Rheumatology and therapy
Published: August 13, 2026
A Practical Guide to Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Journal: Neurology and therapy
Published: March 12, 2026
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: March 11, 2026
The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocol.
Journal: Frontiers in neurology
Published: March 05, 2026
Cutaneous alpha-synuclein deposition informs autonomic function in individuals with early-stage multiple system atrophy.
Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society
Published: February 13, 2026
ALSUntangled #81: Pyridostigmine (mestinon®).
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: November 06, 2025
Laboratory Evaluation of Peripheral Neuropathy.
Journal: Neurologic clinics
Published: October 29, 2025
Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia.
Journal: Annals of clinical and translational neurology
Published: September 12, 2025
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.
Journal: Nature aging
Published: June 30, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study.
Journal: Rheumatology and therapy
Published: March 21, 2025
Last Updated: 09/26/2026